ABSTRACT The fluorescent probe anilinonaphthalene-8-sulfonate binds to adipocyte lipid binding protein at a site that competes with normal physiological ligands, such as fatty acids. Binding to the protein is accompanied by a relatively large increase in fluorescent intensity. To correlate the major change in optical properties and to determine the mechanism of competitive inhibition with fatty acids, the crystal structure of the protein with the bound fluorophore has been determined. In addition, the thermodynamic contributions to the binding reaction have been studied by titration calorimetry. Because the binding site is in a relatively internal position, kinetic studies have also been carried out to determine k on . The results indicate that binding is not accompanied by any major conformational change. However, the negatively charged sulfonate moiety is not positioned the same as the carboxylate of fatty acid ligands as determined in previous studies. Nonetheless, the binding reaction is still driven by enthalpic effects. As judged by the crystallographic structure, a significant amount of the surface of the fluorophore is no longer exposed to water in the bound state.
INTRODUCTION
Intracellular lipid binding proteins (iLBPs) have the unusual property of having a hydrophobic ligand binding site within a water-filled cavity inside an underlying ␤-barrel structure. A fluorescent probe, 1-anilinonaphthalene-8-sulfonate (ANS) has been shown to be a competitive inhibitor for binding of the most prevalent ligand, fatty acids (Kane and Bernlohr, 1996; Kurian et al., 1996) . ANS is also a commonly used probe employed to observe the character of different regions of globular and membrane proteins (Slavik et al., 1982) . Its covalent structure is illustrated in Fig. 1 . Crystallographic studies of the bound form of ANS would provide some insight into what binding environment led to changes in ANS fluorescence.
Binding of ANS to several different iLBP family members shows that there is a large fluorescent enhancement accompanied by a blue spectral shift. The binding of ANS to proteins belonging to the iLBP family includes studies of intestinal and adipocyte fatty acid binding proteins, cellular retinol binding protein, and cellular retinoic acid binding protein (I) . In all of the iLBP family members, the emitted intensity maximum is shifted from 525 nm to ϳ470 nm (Kane and Bernlohr, 1996; Kurian et al., 1996) . For intestinal fatty acid binding protein, the ratio of the quantum yield for the bound versus free ANS in aqueous solution is of the order of 160 . Recognizing some small variation, the fluorescent enhancement experienced by the fluorescent probe appeared to be similar for the fatty acid and retinoic acid binding proteins, but was reduced by ϳ 1 ⁄2 for the cellular retinol binding protein.
The two binding studies mentioned above established the stoichiometry as one ANS per iLBP molecule (Kane and Bernlohr, 1996; Kurian et al., 1996) . Since the binding cavity for the fatty and retinoic acid binding proteins contains two buried arginines that interact with the carboxylate of the hydrophobic ligands, it is reasonable to expect the sulfonate moiety of ANS to locate near these arginine side chains. In the retinol binding proteins, where the ligand is neutral, these two internalized arginine sites are present as glutamines (Banaszak et al., 1994) . ANS still binds to cellular retinol binding protein, but with a lower affinity and a reduced fluorescent enhancement.
The dissociation constants for ANS binding to the fatty acid binding proteins ranged from ϳ500 nM to 5 M. In the case of intestinal fatty acid binding protein, ANS binding was also studied by isothermal titration calorimetry . The K D values determined by the two methods were in general agreement. The calorimetric analysis produced a value for ⌬H and indicated that most of the binding energy was derived from the enthalpic contribution. The chemical studies also demonstrated that the binding of ANS to the iLBPs competes with fatty acid binding. This then suggests that the location of the ANS binding site is within the cavities of the iLBPs. The competitive nature of ANS binding also made it possible to study fatty acid affinity (Kane and Bernlohr, 1996; Kurian et al., 1996) .
While the use of ANS as a conformational probe continues to increase, few detailed structural data are available on the factors contributing to the changes in fluorescent properties. A single crystallographic study describes the binding of ANS to ␣-chymotrypsin in both solution and crystalline environments Johnson et al., 1979) . The fluorescent enhancement for ANS bound to ␣-chymotrypsin appears to be similar to that observed upon binding to the iLBPs, but was strongly pH-dependent . The crystal structure demonstrated that ANS was bound at a surface site. In this unrefined crystallographic study of the chymotrypsin complex, the aniline-ring was approximately coplanar with that of the naphthalene moiety .
The quantum yield and fluorescent lifetime of a bound fluorophore are highly dependent on the absence of nonradiative transitions (Slavik et al., 1982) . The very high quantum yields for ANS bound to adipocyte lipid binding proteins (ALBP) and intestinal fatty acid binding protein (IFABP) suggest that the pathways of energy transfer through excited state interactions have been limited, most likely by a partial occlusion of the ANS from bulk solvent. In the crystallographic analysis that follows, the conformation and interactions of ANS with the protein ALBP are analyzed in detail. The ALBP crystals contained two molecules per asymmetric unit and a comparison between the conformations of the two ANS molecules will be given. Additionally, a comparison between the ANS conformations as bound to chymotrypsin and ALBP will be made. Finally, characterization of the ALBP/ANS reaction using isothermal titration calorimetry and stopped flow kinetics will be presented. The kinetic results proved complex, and could not be explained by a pseudo-first-order reaction.
MATERIALS AND METHODS

Expression, purification, and preparation of co-crystals
Native murine ALBP was expressed and purified as previously reported (Xu et al., 1991) . Pure ALBP was concentrated to ϳ10 mg/ml in 12.5 mM HEPES pH 7.2, 50 mM NaCl. The NH 4 ϩ salt of ANS was dissolved in 12.5 mM HEPES pH 7.2, 50 mM NaCl, and the concentration verified spectrophotometrically (⑀ 280 ϭ 4990 M Ϫ1 cm Ϫ1 ). This ANS stock was added to the ALBP solution so a 2:1 ANS/ALBP stoichiometry was achieved without significant dilution of the ALBP. The incomplete factorial and novel matrix methods of crystallization screening were employed (Carter and Carter, 1979; Jancarik and Kim, 1991) using the vapor-diffusion/ hanging drop procedure. Crystals formed at 0.1 M HEPES pH 7.5, 2% v/v PEG 400, and 2.0 M (NH 4 ) 2 SO 4 .
X-ray methods
X-ray diffraction data were collected at room temperature on a Siemens multiwire area detector, with CuK ␣ radiation from a Rigaku RU-200 generator equipped with a graphite crystal monochromator. Data were collected with a crystal to detector distance of 11.7 cm and a crystal rotation of 0.25°between frames. Data collection statistics are reported in Table 1 . The XENGEN suite of programs was used to process the initial data and determine the space group.
Model refinement
Starting phases were derived from the coordinates obtained from an isomorphous crystal form of ALBP modified with a pyridoxamine group (Ory et al., 1998) . Coordinates of the pyridoxamine moiety were removed, and further refinement of the structure was carried out in X-plor (Brunger et al., 1987) , with initial rigid body refinement being followed by simulated annealing (Brunger, 1988) . Multiple rounds of positional and B-factor refinement were accomplished using a bulk-solvent correction (Jiang and Brunger, 1994) . The ANS was added to the structure and fit to both 2͉F o ͉-͉F c ͉ maps contoured at 1 and ͉F o ͉-͉F c ͉ maps contoured at 3. Waters were placed in the model late in refinement, and had to be present in both 2͉F o ͉-͉F c ͉ maps contoured at 1 and ͉F o ͉-͉F c ͉ maps contoured at 3. The water sites were required to be between 2.5 Å and 3.5 Å away from a proper hydrogen bond donor/acceptor atom. The R factor /R free was monitored at all stages in refinement to ensure proper fitting and building of the model (Brunger, 1992 ). Final refinement statistics are presented in Table 1 . All cavity volume measurements were calculated using the algorithm CAST (Liang et al., 1998) and manually inspected for cavity continuity. For cases where NMR structures existed, all volumes of all reported structures were averaged, and standard deviations reported.
Stopped-flow measurements of ALBP/ANS reaction
Kinetic data for the binding reaction were collected on an Applied Photophysics SX.18MV stopped-flow reaction analyzer interfaced to an Acorn FIGURE 1 Electron density maps of ANS. A simulated annealing omit map (left), and final omit map (right), both contoured at 3, illustrating the initial ambiguity of the maps. The C1Ј-N-C1-C2 atoms are labeled for reader reference, especially to Table 2. RiscPC. Both protein and ligand samples were in 20 mM Na ϩ /K ϩ phosphate buffer, pH 7.2, and their concentrations verified spectrophotometrically. ALBP was delipidated before data acquisition by treating with Lipidex resin at 37°C using a batch method. For the stopped-flow study, the protein syringe contained ALBP in phosphate buffer at 10 M, with the ligand syringe containing increasing amounts (40, 60, 80, 100, 200, 300, 400, 500, 600 , and 700 M) of ANS in phosphate buffer. ANS fluorescence was monitored using an excitation wavelength of 380 nm and an emission wavelength of 475 nm. Voltage to the photomultiplier was held constant throughout the data acquisition, and all runs adjusted to a common endpoint to account for native ANS fluorescence. This was verified independently with ANS and buffer alone for initial runs. Runs were collected five times over a logarithmic time scale and averaged by the data collection software. Initial runs were carried out at 25°C, but it was observed that the majority of the reaction was complete (ϳ75% of the calculated maximal amplitude change) in the dead time, even at the lower ANS concentrations. The runs were then repeated at 4°C to better observe the fastest process. All runs were carried out in dim light conditions, and solutions were allowed to equilibrate to 4°C before data acquisition.
Data manipulation of stopped-flow results
The raw data were shifted by the dead time of ϳ2 ms (Tonomura et al., 1978) . The data were fit to one, two, and three exponential equations using KFIT (Neil Millar, ftp://wuarchive.wustl.edu/packages/kinsim/uploads). The KINSIM (Dang and Frieden, 1997) suite of programs and KSIM (Neil Millar) were used to test potential models and fit the data. The reaction was assumed to start at the same zero time point for fitting to all equations. This was done to accommodate the observance that more and more of the fastest reaction disappeared in the dead time of the instrument as ligand concentration increased.
Isothermal titration calorimetry of the ALBP/ANS reaction
Calorimetric analysis was carried out on a Microcal (Northampton, MA) calorimeter. 35.5 M ALBP in 20 mM Na ϩ /K ϩ phosphate buffer, pH 7.2, cell volume 1.3438 ml, was titrated with 15-l injections of 439 M ANS in the same buffer using 15 s per injection and a stirring rate of 400 rpm. All titration runs were followed with reference runs of 439 M ANS injected into buffer alone. The reference runs were then fit to a linear function, and the line subtracted from the raw data to account for heat of dilution and temperature differences between the injection syringe and the bath. Protein and ANS concentrations were verified spectrophotometrically before data fitting, as the enthalpy of binding and the stoichiometry of the reaction is sensitive to the ligand concentration used to fit the data. The raw data were integrated and processed with the Origin 2.9 suite of programs.
RESULTS
Crystallographic analysis of ALBP/ANS complex
General characteristics of the crystallographic data and model results are given in Table 1 . As indicated by the value for R merge , multiple measurements of the same reflections agreed within a satisfactory range. The resolution extended to 2.55 Å and was 95% complete with an overall I/I value above 1.0. As mentioned in the Methods section, the phases were obtained from an isomorphous structure [pdb1a2d.ent in the Protein Data Bank (PDB)]. An ͉F o ͉-͉F c ͉ map was not useful, as the isomorphous structure contained a chemical adduct that partially filled the binding cavity, possibly biasing electron density in the region of ANS. Nonetheless, electron density for the ANS was present during all stages of refinement, but was ambiguous in both the 2͉F o ͉-͉F c ͉ and ͉F o ͉-͉F c ͉ maps. To eliminate ambiguity, the ANS was modeled initially in two conformations within the cavity and refinement carried out in parallel on both structures. After refinement, the shape of the resultant electron density was the same regardless of initial ANS orientation. This new electron density map clearly favored one conformation over the other. Simulated annealing and final omit maps of the ANS group are shown in Fig. 1 . Though the electron density is noncontiguous in the simulated annealing omit map contoured at 3, it is clearly visible and contiguous when contoured at 2 (data not shown).
After refinement, all of the atoms in the ALBP polypeptide chain were accounted for as well as the presence of bound ANS, 1 Cl Ϫ , and 78 water molecules. Since there are two molecules in the asymmetric unit, a crude approximation to the precision of the coordinates is apparent from the RMS difference after superimposing one molecule on another. For C ␣ atoms, the RMS difference was 0.22 Å, and 0.96 Å RMS difference using all atoms. The resolution limit of the data was judged to be of sufficient quality not to enforce noncrystallographic symmetry restraints to the refinement protocol. The crystallographic coordinates for the ANS/ALBP complex have been deposited in the PDB with the accession code 2ANS.
The crystallographic results reveal the ANS ligand bound within the cavity normally occupied by fatty acids. The overall positioning of ANS relative to the C ␣ backbone model of ALBP is illustrated in Fig. 2 . Essentially identical results are obtained independent of which of the two protein molecules in the crystal are observed. Note in Fig. 2 that all of the atoms of the ligand are within the strands of the ALBP ␤-barrel. Fig. 2 also contains a ball-and-stick representation of the long-chain sulfonate, hexadecane sulfonic acid (HDS), obtained from a different crystallographic analysis (LaLonde et al., 1994a) . The coordinates of HDS were placed in the crystallographic coordinates of the ANS-ALBP complex using least-squares methods. Note that a number of the atoms belonging to ANS are in similar positions to those belonging to a fatty acid ligand. Despite clear overlap between the binding site for ANS and previously determined positions for fatty acids, the ANS site is in a significantly different orientation. Essentially, it is "flipped" from the orientation that we expected it to adopt with the negative sulfonate headgroup pointing more toward the portal region. This is the area capped by the ␤C-␤D and ␤E-␤F loops and helix ␣II. It is the aniline ring of ANS that interacts with the normal carboxylate binding pair of R126/Y128.
Because of the substantial fluorescent enhancement of bound ANS, the protein conformation near the ANS in the crystal structure has been studied in detail. The two molecules in the asymmetric unit were analyzed for van der Waals and potential polar contacts using the program HB-PLUS (McDonald and Thornton, 1994) . The principal contacts are shown schematically in Fig. 3 . Numerous hydrophobic contacts with the ANS are made in both molecules, including an edge-to-face interaction of Phe-16 to the naphthyl ring of ANS.
Similar to what was observed in the crystal structure of ␣-chymotrypsin/ANS , the interactions are not strictly hydrophobic. This is not surprising, as the cavity of ALBP is lined with approximately an equal number of polar and hydrophobic amino acids, and it would be difficult for any ligand to make a "strictly hydrophobic" interaction. Some of the interactions, however, are unusual. Perhaps most striking is the relatively close interaction of the benzyl ring of Phe-57 with a sulfonate oxygen of the ANS. To make this interaction, the main chain of Phe-57 moves 1.87 Å and 2.6 Å toward the binding cavity when compared to the native-apo or oleate-bound structures of ALBP, respectively.
Thermodynamic analysis of the ALBP/ANS reaction
By using isothermal titration calorimetry, the enthalpy of binding was measured at nine different temperatures, and the free energy and entropy of binding calculated using the following equations: ⌬G ϭ ϪRTln(K a ), ⌬G ϭ ⌬H Ϫ T⌬S. The results were then used to compute the heat capacity changes for the binding reaction. The results are given in Table 4 . The data used to determine the heat capacity are shown in Fig. 4 . The binding reaction had a ⌬C p , Ϫ220.3 Ϯ 13.4 cal/deg-mol.
The values at 30°C given in Table 4 for ALBP (⌬G ϭ Ϫ8.0 and ⌬H ϭ Ϫ9.6 kcal/mol) can be compared to a similar study by Kirk et al. (1996) utilizing IFABP. Using titration calorimetry, ANS bound to IFABP had a K d of 11.4 M at 30°C. The binding reaction for ANS to IFABP gave values of Ϫ7.1 kcal/mol for ⌬G and Ϫ10.5 kcal/mol for ⌬H. The thermodynamics are clearly very similar, and therefore the binding reactions and probably the fluorescent enhancement to both ALBP and IFABP appear to be comparable. Since they are homologous proteins, this is not surprising. However, the binding cavity of IFABP is smaller than ALBP, which may have some bearing on understanding the structural determinants of the interaction and will be discussed in more detail in the Discussion section.
Kinetic analysis of the ALBP/ANS reaction
To further characterize the ligand binding reaction, stoppedflow analysis was performed to determine the reaction rates. The kinetic studies were carried out at varying concentrations of ANS, and the raw data are shown in Fig. 5 D. The kinetic data did not satisfactorily fit to a single or double exponential (data not shown), but were adequately repre-FIGURE 2 Binding mode of ANS. A cartoon representation of the crystal structure of ALBP/ANS. ANS is represented as blackened bonds. The structure of hexadecanesulfonate (HDS)-bound ALBP (pdb1lic.ent) was superimposed with the ANS bound structure, and the resultant coordinates for HDS shown as a ball-and-stick. Elements of secondary structure are labeled for reader reference. The portal region is the area between helix ␣II, the ␤C-␤D turn, and the ␤E-␤F turn.
sented by a three-exponential function. As a result of this analysis, plots of the three relaxation times as a function of ANS concentration are shown in Fig. 5 , A-C.
The three-step interpretation results in the fastest step (Fig. 5 A) , being pseudo-first-order with respect to ANS.
The second reaction (Fig. 5 B) is again pseudo-first-order with respect to ANS, but is slower by a factor of ϳ25. The slowest step is zero order with respect to the fluorescent probe concentration, as is apparent in Fig. 5 C. 
DISCUSSION
The fluorescent enhancement accompanying ANS binding to ALBP has been observed to varying degrees with many proteins. The only other crystallographic study examining the nature of protein interactions with this fluoroprobe involved ANS bound to ␣-chymotrypsin. Weber et al. (1979) found in solution and in the co-crystal that ANS bound to ␣-chymotrypsin, but showed fluorescence enhancement only when the pH dropped below 3.6. The crystal structure of the ANS-bound complex was solved at both pH 3.6 and pH 7, and the structure of the ANS analyzed. No pHdependent conformational change was found either in the protein environment surrounding the ANS or in the ANS itself. The authors mention that a structural change is seen in ␣-chymotrypsin below pH 5.0, but do not expand on this finding, nor relate it to ANS binding or fluorescence. Assuming the structural change is not near the ANS binding site, this would suggest the fluorescent enhancement is due to the change in protonation state of the bound ANS and the different interactions available to the protonated form.
The chymotrypsin study was done before the establishment of the Brookhaven structural database and before modern x-ray refinement methods, so no coordinates for the protein-ANS complex are available from the study. The authors did list the coordinates of the ANS alone when bound to ␣-chymotrypsin. We have used them to compare the structure of ANS bound to chymotrypsin, to ALBP, and the crystal conformation of ANS itself. Two angles may be used to describe most of the conformation of the ANS; they are listed in Table 2 . The values of ␣ (dihedral angle between the naphthyl and anilino ring) and the torsional angle defined by C11-N-C1-C2 are reported. The values for molecule A in the small molecule study is roughly similar to the two values of these angles when the ANS is bound to ALBP and to ANS alone, as described in the Weber and Tulinsky report. The similarity between the bound and unbound conformations suggests that the fluorescent enhancement found on binding to a protein is not related to the conformation of the fluorophore, but rather the energy pathways available between the excited state and its surroundings, chiefly bulk solvent.
With ␣-chymotrypsin, ANS binds to a surface site; in binding to ALBP, it is located within a cavity. To see whether any detectable changes occurred, the cavity volumes of both ALBP molecules were calculated using the CAST algorithm (Liang et al., 1998) . These data were then compared to all previously solved structures of ALBP, including studies of the protein with long-chain fatty acids, and the results are shown in Table 3 . Volume calculations have suggested increases in cavity volume as a result of ligand binding to iLBPs (LiCata and Bernlohr, 1998) . In the case of the crystal structure of the ANS/ALBP complex, no such expansion occurs. The cavity volumes of apo-ALBP and ANS bound to ALBP are almost identical, perhaps somewhat smaller. Hence, the relatively small volume expansion observed with ALBP and other iLBPs and accompanying fatty acid binding does not occur with ANS. This means that the number of internalized solvent molecules is approximately the same for complexes of ALBP with the fluoroprobe and more physiological ligands such as fatty acids.
The crystal structure of ANS bound to ALBP reveals an unusual and previously unseen ligand-binding mode for the iLBP family. The negatively charged headgroup of ANS, instead of being coordinated by the R106/Y128/R126 binding triad, interacts with mostly hydrophobic side chains inside the cavity. The only ionic interaction is a weak electrostatic bond between a terminal nitrogen atom of R126 and an oxygen atom of the sulfonate moiety ϳ3.1 Å away. While the binding mode is unusual, it may be due to the nature of the ligand. This structure is the first of its kind with a significant aromatic component bound to a member of the iLBP family.
A comparison of the ANS/ALBP crystal structure with coordinates for other complexes of ALBP was done. It is immediately obvious that ANS and a fatty acid ligand could not occupy the ligand-binding cavity at the same time; considerable atomic overlap exists between portions of the bound ligands (the reader is referred to Fig. 2) . It is also apparent that the location of the sulfonate of ANS and the carboxylates of fatty acids is different. The crystallographic studies indicate that ANS and fatty acid ligands "partially compete." The negative aspect of the structural results is that dissociation constants determined for fatty acid binding by competition with ANS are technically inhibitory constants (K i ), not dissociation constants. They will rely heavily on accurate determination of the binding constant of the ALBP/ANS reaction.
To further explore the binding reaction, isothermal titration calorimetry was used on the ALBP/ANS reaction to determine ⌬H and K d . The results are given in Table 4 . The reaction is entropically opposed above 25.0°C, but this effect is compensated for by a large enthalpy of binding at higher temperatures. This higher enthalpy is a bit unusual due to the lack of any significant ionic interaction similar to those seen for fatty acids. This may call for a slight reevaluation of the binding energy terms of the binding reaction for physiological ligands. LaLonde et al. (1994b) suggested that the majority of the favorable enthalpic binding energy stems from the coulombic interactions of the negative fatty acid headgroup with the positive groups R126 and a waterbridged R106. ANS, however, has an interaction with R126 The volumes were calculated with the CAST algorithm, and visually inspected for continuity (Liang et al., 1998) . All volumes are the "Vol ms" from CAST. They represent a volume "cast" from molecular surface of the crystal structure of ALBP without any ligand.
that is weak at best, makes extensive nonpolar contacts with the binding cavity, and yet has a very high enthalpic contribution. Regardless, the thermodynamic binding profile for ANS is similar to that of other ligands, being driven mostly by a highly favorable enthalpic energy that is offset by unfavorable entropy at physiological temperatures. The large negative heat capacity seen for the ALBP/ANS reaction is consistent with results seen in the binding of ANS to a homologous protein, IFABP. The calculated ⌬C p for the ALBP/ANS reaction is ϳϪ220 cal/deg-mol, while the ⌬C p for the IFABP/ANS reaction is ϳϪ283 cal/degmol . Furthermore, the overall thermodynamic profile is similar for IFABP bound to ANS; the IFABP/ANS reaction is entropically opposed above 15°C, while the ALBP/ANS reaction is entropically opposed above 25°C. Kirk et al. suggest that this negative change in the heat capacity in the case of IFABP is due mostly to the loss of internal hydrogen bonds of waters found in the cavity that are displaced by the ligand . The authors further suggest the degrees of freedom available to cavity waters are fewer when ligand is bound, helping to increase the entropic opposition. Unfortunately, current structural work offers no insight into this possibility.
Comparison of the apo-ALBP structure (1LIB in the PDB) to the ALBP/ANS structure reveals one crystallographically ordered water in the apo state that would theoretically be displaced by ANS binding. The binding of any ligand must displace more than one water molecule. However, the lack of ordered water molecules observed in the ANS region in other ALBP crystal structures suggests that water molecules in this area of the cavity are more highly exchangeable. The entropic opposition to binding can also be explained if the dominant part of ⌬S is due to ANS and its more rigid conformation when bound to the protein than when free in solution.
After verifying that ANS could be used as an accurate measure of the ligand binding reaction, the fluorescent properties of ANS were exploited to explore the kinetics of the binding reaction. Since the static model of ALBP has the binding site within a cavity, various ideas have been offered as to the mechanism of binding. The best way to study the native ligand binding reaction would be to monitor native tryptophan fluorescence transiently in response to added fatty acid, as was done in the case of IFABP (Cistola et al., 1996) . However, previous studies have shown little to no change in the native tryptophan spectra of ALBP in response to various fatty acids (Bernlohr and Simpson, personal communication) . Instead, the ALBP/ANS reaction was followed using stopped-flow methods.
Interestingly, the stopped-flow data exhibited behavior that suggested a complex binding mechanism consisting of two relaxation times dependent on ANS concentration (k 1 obs and k 2 obs in Fig. 5, A and B) , with an event whose relaxation time was most likely not dependent (k 3 obs in Fig. 5 C) on the ANS concentration. The number of reaction mechanisms that may accommodate three reaction times is great. That being said, previous biochemical evidence can help to rule out most mechanisms. Two ligand-dependent relaxation times could be indicative of two binding sites. However, isothermal titration calorimetry and crystallography clearly show a binding stoichiometry of one, and so the second site would have to be extremely weak (in the mM range). Furthermore, all reaction mechanisms that incorporated irreversible steps were eliminated, as the binding constant is not strong enough (ϳ1 M) to be treated as such, nor has any part of this reaction been shown to be irreversible.
Attempts to globally fit the kinetic data to numerous other models were unreliable. This is primarily due to the fact that a single observable, the fluorescent signal of the ANS, is being fit to at least six variables in a mechanism involving two intermediates. Accurate global fits require a higher ratio of observable species to variables to be meaningful. For example, the three different rates could be due to different binding environments within the cavity. Then the final rate was the convergence to a single binding site resembling that seen in the crystal. Fitting of this mechanism, however, would require the fluorescent coefficients of the intermediate species, which are unknown.
The observed rates nevertheless indicate a process that behaves similarly to the expected pseudo-first-order behavior of a simple binding reaction. This is additive with two other processes. The first process is dependent on ligand concentration, an order of magnitude slower than the binding reaction. The second process appears independent of ligand concentration, and occurs at ϳ1 s
Ϫ1
. Further analysis of this reaction using mutants of ALBP suspected to have different ligand binding kinetics [such as V32D/F57H (Ory et al., 1997) ] are needed to better characterize this complex system.
In the kinetics of IFABP binding, a concentration-independent process was also seen, which was fit to a structural isomerization between an open and closed state of the protein (Cistola et al., 1996) . The rate of isomerization was 1000 s Ϫ1 , while the process in the ALBP reaction is 1 s Ϫ1 . This can be reconciled when two things are taken into account: 1) the IFABP experiments were performed at 25°C, and the ALBP at 4°C, and 2) 15 N relaxation experiments on apo forms of ALBP and IFBAP suggest IFABP is more flexible than ALBP (Constantine et al., 1998; Hodsdon and Cistola, 1997) .
To further test and explore the idea of protein flexibility in the binding reaction, all crystal structures of native ALBP solved to date, including the ANS bound structures, were aligned using LSQMAN (Kleywegt and Jones, 1994) , and analyzed as an ensemble of structures. The results are presented as a MOLMOL sausage diagram in Fig. 6 . The deviations in conformation are much smaller because they are all crystal structures, and almost all the entries were refined from the same initial structure. However, some interesting variations are found. As is clearly seen in Fig. 6 , the areas that deviate in main chain conformation among the nine structures are localized to the ␤C-␤D turn and helix ␣II. These same areas are found to be disordered on the microsecond-to-picosecond time scale according to 15 N relaxation experiments carried out with apo form ALBP (Constantine et al., 1998) .
It is unclear whether disorder on this time scale can be correlated with the more discrete disorder seen in apo IF-ABP structure (Hodsdon and Cistola, 1997) . However, this lends further credence to the concept of these areas being flexible, as presumably variations in structure found by crystallography are of a smaller order of magnitude due to crystal packing forces than those found in well-resolved NMR structures.
In summary, ANS provides a novel way to measure dissociation constants using fluorescent methods and competition with physiological ligands such as fatty acids. The crystal structure of the complex demonstrates the nature of the competition. ANS is bound to an overlapping region of the binding cavity seen to interact with fatty acids, but not in the manner expected. The majority of the binding energy derives from enthalpic effects apparently due to favorable nonpolar interactions in the binding cavity. Surprisingly few ionic interactions between ANS and the protein are seen, the only obvious one being a weak interaction between R126 and an oxygen atom of the sulfonate headgroup. A minimum of 10 contacts (3.5-4.5 Å) with nonpolar atoms is made in the crystal structure. Hence, despite the presence of water within the cavity, the fluoroprobe is clearly not experiencing the same environment as it would in the bulk solvent. This change in the surrounding environment is most likely responsible for the fluorescent enhancement. The kinetics of the binding reaction as followed by fluorescent changes is complex, with two processes being additive with the expected pseudo-first-order binding reaction.
